Fosun Pharma stock falls 1.21 percent in October 8 trading

Published on 10/08/2026 at 08:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fosun Pharma stock was trading at HKD 17.97 on October 8, 2026, with a 52-week range of HKD 14.90 to HKD 26.62. H1 revenue rose 4.75 percent.

Fosun Pharma, CNE100001M79, Illustration mit AI erstellt.

Fosun Pharma stock (ISIN CNE100001M79) was trading at HKD 17.97 on the Hong Kong Stock Exchange at 2:20 p.m. HKT on October 8, 2026, down 1.21 percent from the prior close of HKD 18.19. The intraday range ran from HKD 17.96 to HKD 18.50, giving investors a precise view of the session's early price pressure.

Price sits below yearly peak

The Hong Kong-listed H share has moved between HKD 14.90 and HKD 26.62 over the past 52 weeks. At HKD 17.97, the stock stood HKD 8.65 below its yearly high, while its market capitalization was HKD 67.3 billion and trading volume reached 2,360,500 shares on October 8, 2026.

Onvista identifies the security as Shanghai Fosun Pharmaceutical's H share with ticker 2196 and ISIN CNE100001M79. That distinction matters because the A share trades under 600196 in Shanghai, while the reference quote here is the HKEX-listed H share.

H1 growth shifts toward innovation

According to Seeking Alpha in the September 22, 2026, interim-results briefing, Fosun Pharma generated CNY 20.442 billion in H1 2026 revenue, up 4.75 percent year over year. At constant exchange rates, the increase was 7.17 percent, separating underlying operating growth from the reported currency effect.

The product mix provides the more important comparison. Innovative-drug revenue rose 13.84 percent to CNY 4.911 billion in H1 2026, while overseas revenue increased 16.45 percent, according to Seeking Alpha. The figures point to innovation and international sales growing faster than the group's total revenue.

Research spending raises the bar

Fosun Pharma also reported CNY 3.247 billion in R&D expenditure for H1 2026, up 25.66 percent year over year, while operating cash flow reached CNY 2.424 billion, up 13.59 percent, Seeking Alpha reported. For investors, the central test is whether faster innovation growth can offset currency effects and support the H share's valuation.

Fosun Pharma stock trades at HKD 17.97

Fosun Pharma stock was last at HKD 17.97 on October 8, 2026, on the HKEX, with a daily change of minus 1.21 percent and a market capitalization of HKD 67.3 billion.